Adrenomedullary hyperfunction

E4_ADREMEDHYPER

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 E27.5
  • Hospital discharge: ICD-9 2556
  • Cause of death: ICD-10 E27.5
  • Cause of death: ICD-9 2556

2 out of 7 registries used, show all original rules.

102

4. Check minimum number of events

None

102

5. Include endpoints

None

102

6. Filter based on genotype QC (FinnGen only)

102

Control definitions (FinnGen only)

Control exclude
E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E27
Name in latin
Hyperfunctio medullae glandulae suprarenalis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 589 326 256
Only index persons 521 296 225
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 57.31 57.45 57.21
Only index persons 56.12 56.57 55.53

-FinnGen-

Key figures

All Female Male
Number of individuals 102 55 47
Unadjusted period prevalence (%) 0.02 0.02 0.02
Median age at first event (years) 53.08 50.41 56.20

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
91
Matched controls
907
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E27.5
ICD-10 Finland
Adrenomedullary hyperfunction
+∞
116.2
85
*
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
+∞
65.8
55
*
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
+∞
63.0
53
*
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
174.1
46.0
45
5
8700/3-C74.9
ICD-O-3
Pheochromocytoma, NOS, of adrenal gland, NOS
+∞
24.0
22
*
C74.1
ICD-10 Finland
Malignant neoplasm: Medulla of adrenal gland
252.7
20.4
20
*
H02AB09
ATC
hydrocortisone; systemic
252.7
20.4
20
*
BCA30
NOMESCO Finland
Unilateral adrenalectomy
+∞
19.5
18
*
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
+∞
19.5
18
*
BC1CD
NOMESCO Finland
Very extensive CT of adrenal glands
+∞
15.0
14
*
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
+∞
15.0
14
*
8700/3-C74.1
ICD-O-3
Pheochromocytoma, NOS, of medulla of adrenal gland
+∞
13.9
13
*
TPH07
NOMESCO Finland
Cathetrisation of artery
8.4
12.8
30
50
BC5AQ
NOMESCO Finland
Chromaffine tissue SPECT with low dose CT
+∞
10.6
10
*
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
+∞
8.5
8
*
C04AX02
ATC
phenoxybenzamine; oral
+∞
8.5
8
*
D35.59
ICD-10 Finland
Other paragangliom
+∞
7.4
7
*
105
Kela drug reimbursment
Adrenal cortical hypofunction
+∞
7.4
7
*
JN4BD
NOMESCO Finland
Extensive body CT
5.7
7.0
20
43
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.2
6.2
19
44
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.2
6.2
13
18

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
61
12
124.98
113.15
6.3
1.1
—
—
—
0
0
61
13
115.25
111.37
6.3
1.2
0.6
—
nmol/l
—
21
0
56
10
122.96
105.08
5.9
1.1
—
—
nmol/l
—
0
0
42
11
64.21
71.37
5.6
3.3
6.9
3.8
nmol/l
0.50
42
11
40
90
6.67
18.57
1.3
1.2
—
—
—
0
0
23
9
32.45
17.85
1.9
1.4
—
—
—
0
0
53
238
3.55
9.17
6.7
4.7
7.4
7.4
ph
0.47
21
41
10
11
9.97
8.22
1.8
1.8
12.7
15.5
ug/l
—
10
11
21
55
4.55
7.71
7.2
4.2
1.2
1.2
mmol/l
0.45
21
50
61
381
2.50
4.80
15.0
9.1
0.0
0.0
e9/l
0.49
53
316
23
94
2.87
4.26
1.3
1.2
—
—
—
0
0
51
309
2.30
4.11
4.9
7.0
1.0
1.2
inr
2.46
24
92
15
49
3.42
3.99
4.7
3.7
4.2
4.6
pmol/l
0.55
15
44
55
350
2.24
3.88
5.2
4.6
34.6
36.2
g/l
0.86
55
334
30
148
2.45
3.81
3.5
2.9
164.1
75.4
ng/l
0.27
22
111
45
271
2.18
3.57
2.1
2.3
—
—
—
0
0
32
170
2.29
3.42
2.7
2.8
565.1
562.1
mosm/kgh2o
0.02
26
152
23
106
2.51
3.34
6.1
7.3
1.0
1.1
mmol/l
0.34
23
99
50
320
2.10
3.34
2.1
2.0
—
—
—
0
0
41
244
2.14
3.30
3.0
2.9
—
—
—
0
0
41
246
2.11
3.22
2.9
3.0
0.5
0.4
e6/l
0.36
36
185
65
475
2.02
2.87
6.5
4.4
6.5
6.7
mmol/l
0.31
65
437
23
114
2.31
2.84
1.4
1.3
—
—
—
0
0
47
308
1.98
2.83
3.4
3.6
172.6
40.2
e6/l
0.52
39
221
9
24
4.01
2.74
4.6
3.0
—
—
—
0
0
42
269
1.95
2.67
3.1
3.0
67.3
270.7
e6/l
0.40
37
207
6
12
5.24
2.44
5.2
3.4
—
—
—
0
0
33
203
1.92
2.31
5.8
4.7
—
—
—
0
0
6
13
4.83
2.30
1.0
1.0
—
—
—
0
0
6
13
4.83
2.30
1.0
1.0
—
—
—
0
0
13
55
2.56
2.22
1.3
1.3
85.7
116.2
iu/ml
—
7
21
22
119
2.08
2.19
3.0
2.5
11.2
13.3
umol/l
0.82
22
108
86
729
2.15
2.10
26.4
16.6
14.1
13.6
%
1.26
86
720
5
10
5.19
2.09
4.0
2.3
—
—
—
0
0
12
51
2.53
2.04
5.3
5.2
24.6
25.1
mmol/l
0.19
12
51
6
17
3.68
1.86
3.2
2.9
8.1
8.4
kpa
—
6
17
6
17
3.68
1.86
3.2
2.9
5.3
4.9
kpa
—
6
17
15
74
2.20
1.86
5.6
7.8
—
—
—
0
0
6
18
3.47
1.77
1.2
1.6
—
—
—
0
0
40
284
1.67
1.67
5.8
5.3
—
—
—
0
0
32
214
1.72
1.66
7.6
6.6
—
—
—
0
0
62
494
1.65
1.64
11.1
9.9
4.1
4.0
e9/l
0.21
55
436
6
22
2.83
1.45
1.0
1.5
—
—
—
0
0
33
234
1.61
1.35
2.2
3.1
—
—
—
0
0
17
100
1.84
1.33
1.9
1.7
—
—
—
0
0
5
18
2.87
1.30
2.4
1.8
—
—
—
0
0
94
867
2.07
1.27
23.2
15.0
139.2
139.7
mmol/l
0.78
94
843
94
868
2.06
1.27
23.6
15.1
4.0
4.0
mmol/l
1.41
94
842
10
49
2.15
1.27
5.9
4.6
—
—
—
0
0
13
72
1.92
1.21
3.8
4.1
—
—
—
0
0
6
26
2.39
1.20
3.2
2.5
—
—
—
0
0
21
137
1.67
1.17
5.0
2.8
0.8
0.8
mmol/l
0.18
21
129
5
20
2.57
1.16
1.4
1.2
—
—
—
0
0
86
773
1.72
1.16
4.9
4.4
1.9
1.9
mu/l
0.09
80
690
69
597
1.48
1.03
4.2
3.7
—
—
—
0
0
30
221
1.51
1.02
1.6
1.4
—
—
—
0
0
9
50
1.88
0.99
2.8
1.3
293.6
128.9
u/ml
—
9
42
95
894
1.91
0.96
24.7
15.8
83.2
77.2
umol/l
0.49
95
894
6
29
2.13
0.91
2.2
1.6
—
—
—
0
0
25
182
1.49
0.89
1.6
1.5
18.9
22.1
nmol/l
0.45
25
150
6
31
1.99
0.86
5.5
4.2
—
—
—
0
0
0
24
0.00
0.80
0.0
1.3
—
291.6
—
0
17
0
24
0.00
0.80
0.0
1.1
—
2.6
—
0
17
9
53
1.76
0.78
2.6
3.1
—
—
—
0
0
9
56
1.66
0.75
3.2
2.5
3.5
6.1
ug/l
—
9
51
50
425
1.35
0.73
6.8
6.0
1.8
1.8
e9/l
0.06
43
383
38
310
1.36
0.73
4.7
4.0
27.6
38.2
ng/l
0.35
29
211
49
417
1.34
0.71
6.9
5.9
0.0
0.0
e9/l
0.35
42
369
49
417
1.34
0.71
6.7
5.8
0.6
0.6
e9/l
0.22
42
370
28
218
1.39
0.70
3.5
4.1
0.0
0.0
estimate
0.00
11
76
7
43
1.67
0.68
2.4
3.8
—
—
—
0
0
15
106
1.49
0.62
1.5
1.4
440.0
572.2
titre
—
6
23
0
20
0.00
0.61
0.0
3.0
—
52.1
—
0
20
0
22
0.00
0.60
0.0
1.3
—
—
—
0
0
10
66
1.57
0.55
2.0
1.6
—
—
—
0
0
9
65
1.42
0.52
1.7
3.2
66.0
66.8
g/l
—
9
60
5
83
0.58
0.48
1.0
1.4
—
—
—
0
0
7
48
1.49
0.48
2.1
2.1
—
—
—
0
0
0
15
0.00
0.41
0.0
2.6
—
69.5
—
0
15
47
420
1.22
0.40
3.2
3.6
0.0
0.0
estimate
0.00
13
78
5
36
1.41
0.39
1.0
1.1
—
—
—
0
0
5
36
1.41
0.39
2.4
2.1
1.5
1.6
g/l
—
5
31
36
315
1.22
0.38
2.8
2.9
—
—
—
0
0
11
82
1.38
0.36
1.4
1.8
—
—
—
0
0
6
46
1.32
0.33
1.0
1.9
—
—
—
0
0
23
195
1.23
0.32
3.9
5.6
—
—
—
0
0
16
130
1.27
0.31
1.9
1.7
—
—
—
0
0
27
234
1.21
0.30
3.0
3.2
—
—
—
0
0
46
419
1.18
0.30
3.1
3.7
0.0
0.0
estimate
0.00
13
74
7
56
1.27
0.30
2.3
2.7
10.9
9.9
g/l
—
7
50
93
904
1.33
0.29
21.5
12.7
—
—
—
0
0
88
850
1.26
0.27
19.7
13.5
23.3
22.1
mg/l
0.14
76
664
14
114
1.26
0.27
1.7
1.9
—
—
—
0
0
6
83
0.71
0.25
1.3
1.8
—
—
—
0
0
7
93
0.73
0.23
1.1
1.4
—
—
—
0
0
45
416
1.15
0.23
3.9
5.1
0.0
0.0
estimate
0.00
12
79
5
41
1.23
0.22
1.8
4.1
25.4
25.1
mmol/l
—
5
41
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
34
312
1.13
0.19
1.9
1.9
79.5
94.9
pmol/l
0.96
15
149
7
60
1.18
0.18
4.0
5.0
—
—
—
0
0
55
576
0.90
0.16
3.9
4.2
—
—
—
0
0
11
93
1.20
0.15
1.9
1.3
—
—
—
0
0
24
223
1.10
0.10
2.1
3.2
168.5
45.7
mg/l
0.43
18
145
35
332
1.08
0.10
3.8
3.4
—
—
—
0
0
18
165
1.11
0.09
1.9
2.0
—
—
—
0
0
19
175
1.11
0.09
1.7
1.4
5.5
2.5
g/l
0.63
13
103
95
953
0.95
0.08
30.5
19.7
89.9
90.9
fl
1.67
95
940
95
953
0.95
0.08
30.5
19.7
29.9
30.3
pg
1.48
95
939
95
953
0.95
0.08
30.9
19.9
133.6
136.9
g/l
1.23
95
940
6
70
0.85
0.08
1.5
3.0
4.8
5.0
kpa
—
6
70
6
73
0.81
0.08
1.2
1.1
—
—
—
0
0
9
84
1.08
0.07
2.0
4.4
—
—
—
0
0
23
244
0.93
0.07
3.1
3.6
—
—
—
0
0
9
85
1.06
0.07
1.6
4.4
5.3
5.8
kpa
—
9
85
9
101
0.88
0.06
1.4
1.5
—
—
—
0
0
25
239
1.06
0.04
1.6
1.7
1.7
1.4
mmol/l
1.06
20
206
25
241
1.05
0.03
3.4
4.0
19.2
7.3
mg/mmol
0.35
16
149
20
193
1.05
0.01
1.2
1.3
1.0
0.9
u/ml
—
6
52
19
192
0.99
0.00
3.3
3.8
—
—
—
0
0
15
145
1.04
0.00
1.2
1.2
61.5
26.3
iu/ml
—
7
44
79
789
1.01
0.00
18.8
14.0
39.9
40.6
%
0.38
63
597
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
3.5
—
0.8
—
0
8
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
21.4
—
5.6
—
0
5
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
6.5
—
0
6
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
6.6
—
0.6
—
0
5
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
7.8
—
0
5
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
0.00
1.2
1.5
—
—
—
0
0
9
89
1.01
0.00
3.1
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
0.00
0.0
15.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
9.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
5
55
0.90
0.00
4.0
3.8
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
2.5
—
12.2
—
0
8

Mortality – FinRegistry

Association

Association between endpoint E4_ADREMEDHYPER and mortality.

Females

Parameter HR [95% CI] p-value
E4_ADREMEDHYPER 2.134 [1.49, 3.05] < 0.001
Birth year 0.993 [0.98, 1.0] 0.122

During the follow-up period (1.1.1998 — 31.12.2019), 66 out of 254 females with E4_ADREMEDHYPER died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have E4_ADREMEDHYPER.

N-year risk Females Males
1 0.217% No data
5 1.264% No data
10 2.879% No data
15 5.587% No data
20 9.629% No data

Relationships between endpoints

Index endpoint: E4_ADREMEDHYPER – Adrenomedullary hyperfunction

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data